Dr Fraser and the other specialists called for a standardised guidance system on assessing high risk medical devices, the introduction of rules for newer devices such as electronic medical records that are not currently scrutinised, more consistent advice on clinical testing and more information on standards and study results.
Innovative BioDefense says a study is under way testing Zylast's effect on elementary-school absenteeism, and additional research is planned on illnesses on cruise ships and in nursing homes.